Zimmer Biomet Holdings Inc (ZBH)
112.54
+3.69
(+3.39%)
USD |
NYSE |
Nov 15, 16:00
112.47
-0.07
(-0.06%)
After-Hours: 20:00
Zimmer Biomet Holdings Research and Development Expense (TTM): 442.20M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 442.20M |
| June 30, 2024 | 447.50M |
| March 31, 2024 | 456.20M |
| December 31, 2023 | 458.70M |
| September 30, 2023 | 453.40M |
| June 30, 2023 | 438.20M |
| March 31, 2023 | 419.50M |
| December 31, 2022 | 406.00M |
| September 30, 2022 | 394.00M |
| June 30, 2022 | 386.10M |
| March 31, 2022 | 451.70M |
| December 31, 2021 | 435.80M |
| September 30, 2021 | 390.60M |
| June 30, 2021 | 382.70M |
| March 31, 2021 | 305.40M |
| December 31, 2020 | 322.80M |
| September 30, 2020 | 393.10M |
| June 30, 2020 | 421.60M |
| March 31, 2020 | 446.00M |
| December 31, 2019 | 449.30M |
| September 30, 2019 | 429.40M |
| June 30, 2019 | 410.70M |
| March 31, 2019 | 397.70M |
| December 31, 2018 | 391.70M |
| September 30, 2018 | 385.50M |
| Date | Value |
|---|---|
| June 30, 2018 | 381.00M |
| March 31, 2018 | 374.50M |
| December 31, 2017 | 369.90M |
| September 30, 2017 | 370.60M |
| June 30, 2017 | 375.00M |
| March 31, 2017 | 371.00M |
| December 31, 2016 | 365.60M |
| September 30, 2016 | 355.80M |
| June 30, 2016 | 343.50M |
| March 31, 2016 | 306.20M |
| December 31, 2015 | 268.80M |
| September 30, 2015 | 233.70M |
| June 30, 2015 | 196.30M |
| March 31, 2015 | 193.00M |
| December 31, 2014 | 192.10M |
| September 30, 2014 | 187.30M |
| June 30, 2014 | 190.80M |
| March 31, 2014 | 197.70M |
| December 31, 2013 | 203.80M |
| September 30, 2013 | 213.10M |
| June 30, 2013 | 217.20M |
| March 31, 2013 | 219.50M |
| December 31, 2012 | 225.60M |
| September 30, 2012 | 235.20M |
| June 30, 2012 | 242.70M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
305.40M
Minimum
Mar 2021
458.70M
Maximum
Dec 2023
415.04M
Average
428.70M
Median
Research and Development Expense (TTM) Benchmarks
| Stryker Corp | 1.458B |
| Boston Scientific Corp | 1.519B |
| NeuroOne Medical Technologies Corp | 5.731M |
| SINTX Technologies Inc | 8.045M |
| Nutriband Inc | 2.863M |